Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

The first platform to combine real-world cardiology data from millions of people in multiple European countries is set to advance research aimed at improving heart health
News | Cardiovascular Clinical Studies
New European Heart Disease Data Set to Advance Research Aimed at Improving Heart Healt

March 21, 2023 — The first platform to combine real-world cardiology data from millions of people in multiple European ...

Home March 21, 2023
Home
Six-month results from the BIOMAG-I clinical study including intravascular imaging data were presented at CRT 2023
News | Stents Bioresorbable
New Data Highlight Promising Angiographic and Safety Profile of BIOTRONIK’s Third Generation Resorbable Magnesium Scaffold

March 16, 2023 — Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator, presented the latest results of the B ...

Home March 16, 2023
Home
Winners of the ACC 2023 Young Investigators Awards were announced during the American College of Cardiology Together with the World Congress of Cardiology Scientific Sessions, ACC23/WCC. The 18 finalists presenting cutting-edge science represented seven states, three countries and 11 different institutions.
News | ACC
Young Investigator Awards at ACC 2023 Scientific Sessions Recognize Cutting-Edge Science

March 16, 2023 — The American College of Cardiology (ACC) announced the winners and finalists of its 2023 Young ...

Home March 16, 2023
Home
Researchers at the University of Alabama at Birmingham Marnix E. Heersink School of Medicine published a study in the Journal of the American Society of Echocardiography showing that transesophageal echocardiography-guided transcatheter structural intervention was associated with a major complication in 3.6 percent of patients.
News | Cardiovascular Surgery
Study Shows One in 25 Patients Undergoing Transesophageal Echocardiography-guided Transcatheter Structural Cardiac Intervention Suffered a Major Complication

March 15, 2023 — Researchers at the University of Alabama at Birmingham Marnix E. Heersink School of Medicine published ...

Home March 15, 2023
Home
Many patients don’t receive much rehabilitation therapy following a stroke, despite strong evidence that higher amounts can reduce long-term disability, according to a new UCLA-led study that tracked over 500 patients across 28 acute care hospitals in their first year following a stroke.
News | Stroke
Many Patients Receive Too Little Rehab Therapy Following Stroke, Study Finds

March 15, 2023 — Many patients don’t receive much rehabilitation therapy following a stroke, despite strong evidence ...

Home March 15, 2023
Home
US hospital claims data reveals cardiogenic shock patients have an average hospital length of stay of 19.6 days making its intensive patient care cost very high
News | Cardiogenic Shock
Windtree Finds Cardiogenic Shock Has High Cost of US Patient Care and Plans Innovation with the Unique Profile of Istaroxime

March 15, 2023 — Windtree Therapeutics, Inc, a biotechnology company focused on advancing late-stage interventions for ...

Home March 15, 2023
Home
Over 1,000 Patients Enrolled in Landmark SELUTION DeNovo Study
News | Drug-Eluting Balloons
Over 1,000 Patients Enrolled in Landmark SELUTION DeNovo Study

March 14, 2023 —MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo coron ...

Home March 14, 2023
Home
Results Suggest CardiAMP Cell Therapy May Have Ability to Restore and Maintain Heart Function to Previously Non-Functioning Areas of the Heart Up to Two Years After Treatment
News | Cardiovascular Clinical Studies
Positive Echocardiography Data from BioCardia Phase III CardiAMP Cell Therapy Heart Failure Trial Presented at American College of Cardiology Annual Meeting

March 13, 2023 —  BioCardia, Inc., developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2023
Home
The three-decade-old international cutpoint for diagnosing children and adolescents with an enlarged heart misclassifies normal heart size as cardiac damage in adolescents, a paper published in the American Journal of Physiology-Heart and Circulatory Physiology concludes
News | Pediatric Cardiology
Researchers Suggest Novel Cutpoints for Diagnosing Cardiac Hypertrophy in Adolescents and Young Adults

March 13, 2023 —  An enlarged heart, often described as left ventricular hypertrophy, is a sign of early cardiac damage ...

Home March 13, 2023
Home
Additional studies presented at ACC.23/WCC reinforce the clinical value of the Zio suite of products and services
News | ECG
Large Real-World Evidence Analysis of Zio XT

March 13, 2023 —  iRhythm Technologies, Inc., a leading digital health company focused on creating trusted solutions ...

Home March 13, 2023
Home
nari Medical, Inc., a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced positive results from the FLAME study in high-risk/massive pulmonary embolism (“PE”).
News | Pulmonary Embolism
FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System

March 10, 2023 — Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of ...

Home March 10, 2023
Home
A large UW Medicine-Kaiser Permanente study finds modestly increased risk, with a stronger link seen among younger, healthier people.
News | Atrial Fibrillation
Incident Atrial Fibrillation Appears to Heighten Dementia Risk

March 9, 2023 — People with a recent diagnosis of atrial fibrillation (AF), the most common irregular heart rhythm, have ...

Home March 09, 2023
Home
C. Noel Bairey Merz, MD, Director of the Barbra Streisand Women’s Heart Center at the Smidt Heart Institute, received the distinguished achievement of Master of the ACC (MACC) on March 6 during Annual Scientific Session
News | ACC
American College of Cardiology Honors Women’s Heart Disease Pioneer

March 9, 2023 — C. Noel Bairey Merz, MD, FACC, professor of cardiology and the director of the Barbra Streisand Women’s ...

Home March 09, 2023
Home
Use of an antihypertensive to lower blood pressure in obese patients was found effective, according to Target-HTN Trial results presented during the 2023 American College of Cardiology Scientific Session.
News | ACC
Data from Target-HTN Trial Released at ACC23 Supports Use of Antihypertensive to Reduce Blood Pressure in Obese Patients

March 9, 2023 — Positive results from a Mineralys Therapeutics study, the Target-HTN Phase 2 trial, demonstrated ...

Home March 09, 2023
Home
Study will evaluate THERMOCOOL SMARTTOUCH SF Dual Energy Catheter’s potential to enable safer and simpler procedures with the ability to deliver both radiofrequency and pulsed field ablation
News | Atrial Fibrillation
Biosense Webster’s First Dual Energy Catheter to Treat Atrial Fibrillation Begins Evaluation in SmartfIRE Clinical Trial

March 8, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 08, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now